Insights

Exhibiton Event

Jeisys Medical Showcases Advanced Energy-Based Portfolio at ‘2026 KACAS,’ Highlighting Explosive Growth of its Next-Gen Alpha Tip


 
SEOUL, South Korea — Jeisys Medical Inc., a prominent global manufacturer of energy-based medical aesthetic devices, announced its successful participation in the 20th Annual Scientific Meeting of the Korean Association of Clinical Aesthetic Medicine (KACAS 2026), held on May 31 at the Grand InterContinental Seoul Parnas.

Under the overarching theme 'Essence Meets Innovation,' KACAS 2026 served as a high-level hub for leading domestic and international aesthetic physicians to exchange breakthrough clinical paradigms, evolving treatment modalities, and the latest industry trends.

During the symposium, Jeisys Medical anchored the exhibition floor by operating three extensive corporate booths designed to maximize peer-to-peer physician interaction. In tandem with the physical exhibition, the company advanced clinical discourse by hosting four high-impact scientific lectures focused on its flagship energy-based platforms: ‘DENSITY’ (high-frequency RF), ‘POTENZA’ (microneedle RF), and ‘LinearZ’ (advanced HIFU).

The focal point of the exhibition was an artistic large-scale installation of the 'Alpha Tip,' the newly introduced 3rd-generation consumable exclusively engineered for the DENSITY platform. The Alpha Tip is uniquely designed to deliver both monopolar and bipolar radiofrequency energy either sequentially or simultaneously. Capturing the attention of international attendees, the display underscored an extraordinary commercial milestone: supplying over 20,000 units within just four months of its commercial launch.

To enhance physician engagement, Jeisys Medical also implemented an interactive on-site social media activation, driving heavy traffic to its clinical showcases and fostering an immersive brand experience.

"Our active participation in KACAS 2026 provided an exceptional venue to deepen academic and commercial synergy with pioneering clinicians," said an official spokesperson for Jeisys Medical. "Moving forward, we will continuously expand our high-level clinical exchanges with international physicians and implement highly localized, data-driven marketing strategies to accelerate our aggressive expansion into demanding global markets."